Ionic derivatives of betulinic acid exhibit antiviral activity against herpes simplex virus type-2 (HSV-2), but not HIV-1 reverse transcriptase

New ionic derivatives of betulinic acid (1) such as 2 and 5 show strong inhibition against herpes simplex type 2 (HSV-2) replication with minimal cellular cytotoxicity.